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ABSTRACT
Objectives To explore the experiences of endometrial 
scratch (ES) trial participants and site staff of trial 
recruitment and participation, in order to improve the 
experience of participants in future trials.
Design Qualitative study of a subset of participants in the 
ES randomised controlled trial and a subset of trial site 
staff.
Setting A purposeful sample of 9 of the 16 UK Fertility 
Units that participated in the trial.
Participants A purposeful sample of 27 trial participants 
and 7 site staff.
Results Participants were largely happy with the 
recruitment practices, however, some were overwhelmed 
with the amount of information received. Interviewees had 
positive preconceptions regarding the possible effect of the 
ES on the outcome of their in vitro fertilisation (IVF) cycle, 
which often originated from their own internet research and 
seemed to be exacerbated by how site staff described the 
intervention. Some participants appeared to not understand 
that receiving the ES could potentially reduce their 
chances of a successful IVF outcome. Those randomised 
to the control arm discussed feeling discontent; site staff 
developed mechanisms of dealing with this.
Conclusions A lack of equipoise in both study participants 
and the recruiting site staff led to trial participants having 
positive preconceptions of the potential impact of the ES 
on their upcoming IVF cycle. Trial participants may not 
have understood the potential harms of participating in 
a randomised trial. The trial information sheet did not 
clearly state this; further research should assess how such 
information should be presented to potential participants, 
to proportionately present the level of risk, but to not 
unduly discourage participation. The amount of information 
fertility patients require about a research study should 
also be investigated, in order to avoid participants feeling 
overwhelmed by the amount of information they receive 
prior to starting IVF.
Trial registration number ISRCTN23800982.
INTRODUCTION
A wealth of literature exists that qualitatively 
assesses the experiences of participants being 
recruited to trials across various disease areas, 
indicating that participants can find it diffi-
cult to understand the potential harms of 
participating in a study,1 2 and staff experi-
ence challenges in expressing equipoise to 
participants.3 The participant information 
sheet (PIS) has been extensively researched; 
in one study the ‘traditional’ PIS was found 
to oversupply information to 79.5% of partic-
ipants.4 Other studies have identified that, if 
given a choice, participants often opt for a 
shorter version of the PIS.5 6 To our knowl-
edge, the experience of patients participating 
in randomised trials in fertility has not been 
explored, although recruitment techniques 
have been described across two trials.7
The endometrial scratch (ES) trial was a 
randomised controlled trial (RCT) that aimed 
to assess the clinical and cost effectiveness of 
Strengths and limitations of this study
 ► We present data from a purposeful sample of 27 trial 
participants and 7 site staff regarding their experi-
ences of taking part in, and running, the endometrial 
scratch randomised controlled trial.
 ► As far as we are aware, this is the first study to in-
vestigate the experience of fertility patients of being 
recruited to, and participating in, a randomised trial.
 ► We included both participants randomised to the 
control and intervention arms of the trial, plus those 
who did and did not have a live birth after their in 
vitro fertilisation cycle.
 ► Recall may be an issue, as trial participants were 
interviewed on average 17.8 months after they were 
recruited to the trial.
 ► We only interviewed individuals who participated in 
the trial, and therefore, interviews may represent a 
biased view of the experiences of being recruited to 





























































































































2 Chatters R, et al. BMJ Open 2021;11:e051698. doi:10.1136/bmjopen-2021-051698
Open access 
undertaking the ES prior to first time in vitro fertilisation 
(IVF). Participants (women recruited between July 2016 
and October 2018 from 16 fertility centres across the UK) 
were randomly allocated to either receive usual IVF treat-
ment, or the ES procedure, followed by usual IVF treat-
ment. The ES involves scratching the lining of the womb 
(the endometrium) prior to a cycle of IVF and is hypoth-
esised to improve the chances of the embryo implanting 
by improving the receptivity of the endometrium.8 A lack 
of good- quality evidence exists to support the delivery of 
the ES in women undergoing their first cycle of IVF.9 The 
full trial protocol is published elsewhere.10
There are several reasons to investigate the experience 
of participants and staff within this trial. Undergoing 
IVF can be a distressing and emotional experience that 
involves receiving invasive procedures, causing physical 
and mental stress.11 12 Patients receive a lot of information 
prior to their treatment, which has been associated with 
anxiety.13 It is, therefore, important to ensure that partic-
ipation in research does not create an extra burden for 
the patient. Furthermore, as women undergoing fertility 
treatments often seek information from sources other 
than their fertility team (eg, the internet, books and maga-
zines), it is pertinent to ascertain how this affected the 
participant’s experience of recruitment to the trial.14 The 
study involved potentially difficult decisions for partici-
pants, specifically, whether to participate in the trial given 
the 50% chance of being randomised to a novel interven-
tion with unknown benefits or harms, or the treatment 
as usual control group. Qualitative evaluations in other 
trial populations have identified that participants often 
feel discontent when randomised to the treatment as 
usual arm.15 Given that recruiting staff have been found 
to struggle to convey equipoise in previous studies,3 16 it 
is interesting to evaluate if these individuals conveyed 
equipoise, and if this impacted on the participant’s expe-
riences of the trial.
The aim of this qualitative study was to understand 
the experiences of participants being recruited to—and 
participating in—the ES trial, including any issues or 
barriers they faced. We also aimed to understand trial 
site staff’s experiences, with a general aim to improve the 
experience for participants in future trials.
METHODS
Sampling, approach and recruitment
Purposive sampling was used to achieve the maximum 
variation in characteristics across trial participants and 
staff. First, six trial sites were selected, by seeking distri-
bution of the characteristics described in table 1 (site 
sampling attributes). Trial participants who had recently 
completed the trial and had not withdrawn from trial 
follow- up were then sampled from these sites, using the 
attributes presented in table 1 (participant sampling 
attributes).
Site staff (principal investigators (PIs) and research 
nurses (RNs)) from the six selected centres were initially 
sampled for the staff interviews. Due to low staff availability 
and willingness to participate in the interviews, additional 
sites were selected as long as the research nurse was still in 
post and had undertaken recruitment to the trial.
Potential interviewees were initially approached by 
letter or email. If no contact was received, individuals 
were telephoned or emailed approximately 1 week after 
the initial contact was made. Verbal consent was obtained 
immediately prior to the interview via telephone, with the 
conversation regarding consent being audiorecorded.
Research team and reflexivity
One woman (AP, research assistant with a PhD) and one 
man (RC, trial manager with a BSc) conducted the inter-
views with all participants. Both had prior training and 
experience of undertaking qualitative interviews. One 
other female researcher (PK, research assistant with an 
MSc) assisted with data analysis, and a female patient and 
public involvement (PPI) representative (AS, with experi-
ence of fertility treatments and an employee of a patient 
charity—Fertility Network UK) reviewed the interview 
schedule and this manuscript.
RC managed the ES Trial from the start; AP commenced 
her involvement more recently prior to the start of this 
Table 1 Site and participant level sampling attributes
Attribute Categories
Site sampling attributes
  Site type NHS site/privately owned
  Size of centre Number of IVF cycles undertaken per year
  Consent rate of centre The proportion consented relative to those screened
Participant sampling attributes
  Intervention status ES received, ES declined, treatment as usual
  Age 30 or below, above 30
  Duration of infertility Less than 36 months, 36 months or more
  Outcome of first cycle of IVF Live birth, no live birth
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qualitative study. A relationship between site staff and RC 
was therefore already formed, which was also true for AP 
but to a lesser extent. Site staff would have been aware of 
the interviewer’s involvement in the design and delivery 
of the trial and their reasons for doing the research.
The interviewers had no involvement in the clinical 
care of the trial participants, nor had they had previous 
contact. Participants would have been aware of the inter-
viewer’s reasons for undertaking the research and may or 
may not have been aware of the interviewers’ involvement 
in the trial in which they participated.
Data collection
A semistructured interview schedule was used to guide the 
interviews—with separate schedules being used for trial 
participants and site staff (see online supplemental files 
1; 2). The schedules were pilot tested in one interview per 
schedule, and adjustments were made following discus-
sions between AP and RC; the pilot interview is included 
in the analysis. The participant interviews were under-
taken prior to the staff interviews in order to allow themes 
from the former to be discussed with staff. Prompts were 
used during interviews and repeat interviews were not 
carried out.
Interviews were audiorecorded and transcribed 
verbatim. There were no other individuals present at the 
interviews, except for, in a few instances, the participant’s 
child. The interviewee recorded notes after each inter-
view. Interviews with trial participants ranged from 4.5 to 
21.5 min, and those with staff were 19.5 to 57.6 min.
The trial participant interview schedule covered the 
participants’ experience of recruitment and participa-
tion in the trial. The staff interview schedule included the 
staff’s experience of recruitment and their overall experi-
ence of delivering the trial at their site.
All interviews were undertaken by telephone. Data satu-
ration was discussed between RC and AP separately for 
staff and trial participant interviews.
Data analysis
An inductive thematic analysis was used to analyse the 
data, which was undertaken within a phenomenolog-
ical framework. We used Braun and Clarke’s reflexive 
thematic analysis framework, which involves six phases of 
analysis—familiarisation, initial coding, theme construc-
tion, reviewing themes, defining themes and producing 
the report.17 Two researchers (AP and RC for the trial 
participant interviews, and PK and RC for the staff inter-
views) developed the coding structure separately by 
coding a small number of transcripts (four for the partic-
ipant interviews and two for the staff interviews). NVivo 
(V.12) was used to undertake all analyses. The researchers 
then met and resolved any differences in coding in order 
to develop the final list of codes. All other transcripts 
were then coded by one researcher, either AP or RC for 
the trial participant interviews, and RC or PK for the 
staff interviews. The coding trees were formed of overar-
ching themes that were related to the overall aims of this 
qualitative study—the experience of receiving/delivering 
ES, reasons for participants deciding not to receive ES 
after being randomised to do so, preconceptions of the 
ES procedure, and experiences of recruitment. However, 
in this manuscript, the experience of receiving/deliv-
ering ES is not reported in order to reflect only those 
themes that have the potential to improve the experience 
of participants in future studies. RC undertook all anal-
ysis steps after coding, including formation of themes and 
writing of the report. Interviewees did not feedback on 
the findings or transcripts. After analysing the transcrip-
tions no new themes emerged, thus, data saturation was 
determined to have been reached.
Patient and public involvement
Input into the design of the study, interview schedules and 
patient facing materials were sought from the Sheffield 
Reproductive Health Research Public Advisory Panel and 
the trial’s public involvement representative (AS).
RESULTS
Interviews and characteristics of participants
Forty- four trial participants were approached to partic-
ipate in the study, of which two actively declined to 
participate and 15 either did not respond or were not 
contactable. As a result, 27 trial participants took part.
Interviewed participants had an average dura-
tion of infertility of three years (range 11 months to 
8 years 6 months) and were interviewed, on average, 
17.8 months after they were randomised into the trial 
(range from eight to 33 months). Most participants 
were in the 33–37 years age range, with ages ranging 
from 21 to 37 years. Participants were recruited from 
National Health Service (NHS) sites, except for four 
participants, who were recruited from a privately run 
centre (site six). The demographics of the trial partic-
ipants that took part in this study are summarised in 
table 2.
Seven site staff (one principal investigator (PI) and 
six research nurses) took part. Fifteen participants were 
invited (seven PIs and eight research nurses)—one partic-
ipant actively declined due to lack of time, five partici-
pants did not reply following multiple contact attempts. 
Interviews were attempted to be scheduled for two indi-
viduals but a mutually agreed time could not be found. 
The characteristics of the participating site staff can be 
found in table 3.
Trial participants and site staff discussed four major 
themes during the interviews—the experience of 
recruitment to the trial, the written materials that 
were provided at recruitment, the lack of equipoise in 
both trial participants and site staff and the demoral-
ising effect this had on some participants randomised 
to the control arm, and the reasons for withdrawing 
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Experience of the general recruitment process
Trial participants were generally happy with the recruit-
ment process.
I think it was all done really well. It was just, it was really well 
explained and I don’t … think, if it was happening again, … 
I wouldn’t change anything about it. Participant 2—Site 8
Participating in research while undergoing IVF was 
seen by many as ‘exciting’ and ‘interesting’, and provided 
an alternative focus for two participants.
I think it’s in a way it was actually it was quite a good thing 
because I think it gave me something else to focus on […] it was 
quite nice to have something that was being discussed where I 
felt actually this has got a wider benefit. Participant 4—Site 4
Three participants felt that the approach to take part 
in the trial was too informal, with the participants either 
having to ask about the trial, or the trial being mentioned 
at the last minute when there were previous opportunities 
to raise this.
Table 2 Characteristics of Interviewed trial participants
ID Age range at randomisation Live birth recorded? Randomisation arm
Site 1
  Participant 1 33–37 No ES
  Participant 2 33–37 Yes ES
  Participant 3 27–32 No ES
  Participant 4 27–32 No ES
  Participant 5 27–32 No ES
Site 2
  Participant 1 27–32 Yes ES
  Participant 2 27–32 Yes ES
Site 3
  Participant 1 33–37 No ES
Site 4
  Participant 1 33–37 No ES
  Participant 2 33–37 Yes ES
  Participant 3 33–37 Yes TAU
  Participant 4 33–37 No ES
Site 5
  Participant 1 27–32 Yes ES
  Participant 2 27–32 Yes TAU
  Participant 3 21–26 No ES
Site 6
  Participant 1 27–32 Yes TAU
  Participant 2 27–32 Yes ES
  Participant 3 33–37 Yes ES
  Participant 4 27–32 No TAU
Site 7
  Participant 1 33–37 No ES
  Participant 2 33–37 Yes ES
  Participant 3 21–26 No ES
  Participant 4 33–37 Yes TAU
Site 8
  Participant 1 27–32 No TAU
  Participant 2 33–37 Yes ES
  Participant 3 27–32 No ES
  Participant 4 33–37 No TAU
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I don’t know if it should be more formal really, because 
it was just kind of, if they remembered on that day that I 
would be a possible candidate …, maybe you should get 
it in a pack or something at the beginning. Participant 
2—Site 1
Written information provided at recruitment
Four participants could not recall the recruitment mate-
rials, due to the time that had elapsed since they were 
recruited. Of those that could, five participants stated 
that the materials were clear and informative.
I thought the information sheet was really useful and infor-
mative. Participant 4—Site 7
There were differences in opinion with regards to the 
amount of information that trial participants were asked 
to read during the recruitment process, with some partic-
ipants stating that the materials were not too onerous to 
read.
I think it was maybe like a double sided page it wasn’t kind 
of too much. Participant 2—Site 2
However, others reflected on the amount of infor-
mation provided more negatively, with two participants 
discussing the amount of information they received as 
‘overwhelming’.
It can be very overwhelming, having lots of trial information 
given to you at the same time as all your IVF treatment. It 
just means that your pack of information to read through, 
I think I had about twenty different documents or leaflets. 
Participant 4—Site 7
One participant suggested that the PIS should contain 
more information about related studies.
After reading about other studies in the newspapers like The 
Guardian, it might have been also interesting to hear a little 
bit about other studies that were going on… Because, I think 
when I did read about this study in The Guardian…and it 
suggested that it wasn’t helpful. There was part of me that 
I think became a little bit angry that maybe I’d put myself 
through it at the time. Participant 2—Site 7
Equipoise
Participant’s lack of equipoise were exemplified by eigh-
teen of the interviewed participants stating that a major 
reason to participate in the trial was to increase their 
chances of a positive outcome from their IVF cycle.
Obviously if they’d have said to us the Scratch trial proba-
bly won’t have improved our chances of getting pregnant, I 
probably wouldn’t have taken part. So we did it on the basis 
that we wanted to be on the clinical sample so that we could 
improve our chances of getting pregnant. Participant 1—
Site 7
Outside of the trial, the privately run site (site 6) offered 
the ES for a fee, whereas the NHS sites did not offer it at 
all to women undergoing their first IVF cycle. Two of the 
four participants from the private site participated in the 
trial to receive a ‘free’ ES. However both of these partic-
ipants seemed to be well informed regarding the lack of 
evidence to support the use of ES in this population.
They went through all the extras that could be added 
on to our treatment…they talked about the fact that 
they were involved in the scratch trial and that it was 
our first round of IVF. We thought that was probably 
a good way to do it, rather than to pay for it, if we get 
lucky and we have it then brilliant and if we don’t, 
you don’t yet know how successful it is. Participant 
3—Site 6
There seemed to be a lack of understanding of the 
potential for the ES to negatively affect the chances of 
live birth, with five trial participants believing that the ES 
procedure could not ‘harm’ them.
There wasn’t anything that could potentially harm my 
chances of success. It wasn’t, you know, it wasn’t like trying 
out a new medicine or anything like that. Participant 2—
Site 8
Source of positive preconceptions
Trial participants discussed that a small number of site 
staff supported their positive preconceptions, sometimes 
in a subtle way.
You don’t know whether it helps or not but there seems to be 
this influence from some within the clinic that almost nudge 
nudge, wink wink, you know,’ you’re gonna be fine because 
this really does help. Participant 2—Site 7
In other cases, the trial participant reported that 
they believed site staff thought ES would increase their 
changes of a live birth
Basically they said: ‘It’s completely up to you, it’s something 
that we’re giving to you, you can decide.’ … obviously they 
do believe scratches increase chances of success. Participant 
3—Site 7
However, for some participants, the information 
provided by site staff ensured they were aware that there 
Table 3 Characteristics of interviewed site staff
ID NHS/private Gender
PI- SITE1 NHS Female
RN- SITE1 Female
RN- SITE3 NHS Female
RN- SITE4 NHS Female
RN- SITE5 NHS Female
RN- SITE6 Private Female
RN- SITE9 NHS Female
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was insufficient evidence to suggest that the procedure 
will improve their chances of success.
The consultant suggested that there wasn’t much evidence 
about whether the scratch was helpful or not when it comes 
to success of IVF. Participant 1—Site 8
Participants also sought information from other 
sources, most frequently from the internet. For five partic-
ipants, the internet provided the participant with positive 
preconceptions of the effect of the ES on their upcoming 
IVF cycle.
Just the success rate for the people who were trying to do IVF; 
who were trying to have babies. The success rate after the 
scratch was high. Participant 2—Site 5
However, for two participants, reading information on 
the internet led them to a position of equipoise.
I wasn’t sure, because some studies said it was successful, 
others said it wasn’t, so I was on the fence. Participant 
2—Site 1
Discontent when randomised to the control arm of the trial
Positive preconceptions of the effect of the ES on the 
outcome of their IVF cycle led five out of the eight 
interviewed participants randomised to the control arm 
feeling some level of discontent with the outcome of 
randomisation. Some participants discussed feeling slight 
disappointment.
I think there was a slight bit of disappointment which is 
ridiculous really because it’s randomised. I wasn’t sort of 
like devastated or anything like that… It was, that’s what 
current practice is, to not have the scratch for a first time if 
under 35 so I was just like well we’ll go with that and see 
what happens. So I didn’t dwell on it or anything like that. 
Participant 4—Site 7
For others, randomisation to the control group trig-
gered significant demoralisation.
I was really quite disappointed and quite emotional when 
I, didn’t get on the Scratch trial itself because I was wor-
ried that my chances of getting pregnant were minimized. 
Participant 1—Site 7
Staff awareness of positive preconceptions and 
demoralisation
Site staff were aware of the trial participant’s positive 
preconceptions.
They would generally say ‘oh I’ve heard about the procedure 
and it can benefit the chances of you getting pregnant’. 
RN- SITE4
In order to attempt to dispel any positive preconcep-
tions during the recruitment process, site staff spent time 
explaining the lack of an evidence base for ES, and the 
need for an RCT, to potential trial participants.
We did explain to them comprehensively the evidence, around 
the Endometrial Scratch and the requirement for a big trial 
like this to be conducted for us to be able to know the answers 
and to know whether they should be offered to all patients 
going through forward for IVF. PI- SITE1
However, site staff reported that participants seemed to 
struggle to understand the need for a control arm when 
some studies reported a benefit to having the ES.
Sometimes patients found it difficult to accept that if there 
has been some study that indicate potential benefit, then 
patients found it difficult to accept that they could be ran-
domised into the control arm. PI- SITE1
Many site staff were also aware of some participant’s 
disappointment of being randomised to the control arm.
Some people did express great disappointment and in partic-
ularly that way round actually it was nearly always the ones 
that had wanted it. RN- SITE6
Staff described mechanisms they had developed for 
dealing with this disappointment, summarised in table 4.
Reasons for withdrawing from the ES
Seven participants were interviewed that, having been 
randomly allocated to receive the ES, did not receive it. 
None of the reasons for withdrawing were related to equi-
poise; five participants declined the ES due to reasons that 
were out of the control of their fertility centre (illness, 
holidays and work commitments). Two participants stated 
reasons for declining ES that could have been prevented. 
For one, the site forgot to check the participant’s records 
for a recent smear test result.
We were scheduled to start the IVF and then I got a call 
from one of the nurses and she said ‘Oh I’ve just checked 
your records and it turns out you’re overdue a smear test, 
we can’t proceed with the IVF until you’ve had a smear test. 
Participant 1—Site 5
For the other, the site did not tell the participant to 
refrain from sexual intercourse in the menstrual cycle 
in which the ES was being performed. This participant 
recommended that discussions around abstinence should 
be more prominent in the recruitment process.
I think that, that discussion [abstinence from sexual in-




This qualitative study demonstrates that participants 
recruited to the ES Trial were, on the whole, happy with 
the trial recruitment practices. A small number of partici-
pants felt that the invitation to participate in the trial was 
too informal, and a minority described the amount of 
written material they received as ‘overwhelming’. There 
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interviewees with regards to the potential effect of the ES 
on the outcome of the upcoming IVF cycle. Trial partic-
ipants had positive preconceptions of the ES procedure, 
which often originated from their own internet research, 
and in some instances, participants indicated that they 
believed site staff supported these preconceptions. 
Some trial participants appeared to not be aware that 
receiving the ES could potentially reduce their chances 
of a successful IVF outcome. This, coupled with the 
positive preconceptions of the ES, led to dissatisfaction 
among some participants randomised to the control arm. 
Participants from the private centre had a similar expe-
rience to those recruited from NHS centres, except that 
those recruited from the private centre stated a reason to 
participate in the trial was to receive a free ES, which at 
the time, was offered at an extra cost by their centre.
Strengths and limitations
A strength of this study is that it included a purposeful 
sample of women that participated in a large RCT, 
ensuring variation in trial arm (control or intervention), 
and live birth status. We also interviewed staff in order 
to seek their experiences. A limitation includes that only 
those that participated in the trial were interviewed, with 
those participants that withdrew from the trial not being 
interviewed. This may result in a skewed reflection of the 
experience of recruitment to the trial. In addition, partic-
ipants were interviewed, on average, 17.8 months after 
they agreed to participate in the trial, and furthermore, 
were interviewed after their IVF cycle had completed. 
This therefore results in participants reflections on their 
experiences being clouded by time, and being affected by 
the outcome of their IVF cycle.
Comparison with existing literature
Our study mirrors the findings of other studies that have 
described that potential participants have different infor-
mation needs, and may require different versions of the 
PIS;5 6 the discontent felt by participants when randomised 
to the control group of an RCT;18 19 participants seeking 
information from internet sources;14 and the motiva-
tion to receive the intervention has been reported as a 
major reason participants decide to take part in inter-
ventional trials.20 21 In this study, site staff tried to repo-
sition the participant’s positive preconceptions of the 
ES by explaining the evidence base, which has also been 
reported in other studies.15 20 However, it appears that in 
some cases, participants received cues from site staff that 
the ES may benefit them, despite having no evidence to 
support this. Staff have been found to communicate equi-
poise poorly in other studies, including providing inbal-
anced descriptions of trial treatments and predicting 
RCT outcomes.16
Other studies have also reported that participants 
overestimate the benefits, and underestimate the risks, 
of participating in research.1 2 Our study adds to this 
evidence base by reporting that, in our study, participants 
‘arrived’ with positive preconceptions, which, in the most 
part, originated from the internet. This, coupled with 
subtle signals from recruiting site staff, led to positive 
preconceptions of the potential effect of the ES proce-
dure on their IVF outcome, and potentially an underesti-
mation of the potential harms of the procedure. This may 
have been exacerbated by the time- sensitive nature of 
fertility treatment and the desire for a positive outcome; 
both clinicians and patients have been reported to feel 
the need to improve the outcomes of treatment immedi-
ately following a failed treatment cycle.22
Implications
Recruiting staff should be aware that participants may 
base their decision to participate in an RCT on internet 
research, which risks participants making their own 
subjective interpretation of the evidence, and may result 
in overly positive preconceptions of the potential bene-
fits—and a downplaying of the potential harms—of 
receiving the novel intervention.
Staff should also be aware of subtle cues that may 
suggest to the participant that the trial intervention may 
Table 4 Methods site staff used to deal with participant’s disappointment at being randomised to the control arm of the trial
Method of dealing with disappointment Quote
Explain the importance of the control group ‘So I think its explaining the importance of being in that control group to them. 
And how we can, you know, we don’t know if there was any benefit until we’ve 
actually, that’s the whole purpose of doing the trial, to answer a question.’ RN- 
SITE1
Describe the lack of evidence to support ES ‘Try and sort of explain that, there was no evidence whether it was a benefit 
anyway, and that normally if they were going through their treatment, I understand 
they wouldn’t be having a Scratch, so it wasn’t as if they missing out on anything.’ 
RN- SITE6
Explain the increased contact with staff that 
participating in research allows
‘If it’s the control you know it’s a bit of extra contact with people and I would 
always say ‘look I’m here in the unit, you’re not having the Scratch, but if I can 
help you in any other way, feel free to ring the research mobile'. You know to try 
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be beneficial to them. The control group should be intro-
duced with similar emphasis to the intervention group, 
however, discontent once randomised to the control 
group may still be felt—we present three ways that this 
was lessened by site staff in our trial (see table 4). Other 
studies have provided recommendations to guide ‘recruit-
ment conversations’ in surgical trials—in the opinion of 
the authors, these guidelines are applicable to studies 
outside this specialty.23–25
In order to improve the information provided to partic-
ipants during the informed consent process, some partic-
ipants may require more detailed information about the 
research literature, including the potential harms of the 
intervention being tested. The authors reflect that the ES 
trial PIS did not explicitly state the evidence for or against 
the ES procedure, nor did it explicitly state the ES may 
potentially harm the chances of a successful IVF outcome. 
PPI input was sought into the PIS, but PPI representatives 
did not comment on the lack of a discussion of the poten-
tial harms.
Improvement to trial participant’s understanding of 
the harms of taking part in research, and the role of 
the control group, may improve the quality of informed 
consent. This, in turn, may lead to reduced attrition from 
the trial, especially differential drop- out, where a different 
proportion of participants drop- out from one trial arm.26 
Reduced attrition may lead to improved external validity 
of the trial.27
Future research
Future research should focus on how the potential harms 
of taking part in a study can be relayed to participants, in 
order to deal with overly positive preconceptions. Details 
of the potential harms of participating in a study have to 
be clearly stated in the PIS in clinical trials of an investiga-
tional medicinal product (CTIMPs). This issue may have 
not been given enough consideration in non- CTIMPs; 
such information could be reviewed by research ethic 
committees prior to providing ethical approval. Check-
lists to assist PPI representatives in reviewing important 
patient facing documentation (including a prompt to 
ensure the potential harms are adequately discussed) 
could be devised.
Other methods of providing information about the 
trial to potential participants should be explored, possibly 
by providing participants with a choice of levels of infor-
mation, as suggested in previous studies.6 28 The use of 
multimedia to inform participants has been assessed 
within various studies with a trial, finding that such 
mediums did not significantly impact on recruitment to 
the trial.29 30 However, the ‘quality’ of informed consent, 
and the participant’s understanding of the research, was 
not assessed. Patient acceptable alternatives to the patient 
information sheet should be investigated, in order to 
reduce the burden on patients at the start of their fertility 
treatment.
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